laryngeal squamous cell cancer
Recently Published Documents


TOTAL DOCUMENTS

38
(FIVE YEARS 5)

H-INDEX

10
(FIVE YEARS 0)

2021 ◽  
pp. 019459982110492
Author(s):  
Rohith S. Voora ◽  
Bharat A. Panuganti ◽  
Mitchell Flagg ◽  
Tyler Nelson ◽  
Nikhil V. Kotha ◽  
...  

Objective Recurrence is known to predict laryngeal squamous cell cancer (LSCC) survival. Recurrence patterns in T4a LSCC are poorly characterized and represent a possible explanation for observed survival discrepancies by treatment rendered. Study Design Retrospective database review. Setting Veterans Affairs national database. Methods Patients with T4a LSCC between 2000 and 2017 were identified and stratified by treatment (chemoradiotherapy [CRT] vs total laryngectomy + neck dissection + adjuvant therapy [surgical]). Primary outcomes were locoregional and distant recurrence. Secondary outcomes of overall mortality, larynx cancer mortality, and noncancer mortality were evaluated in Cox and Fine-Gray models. Results A total of 1043 patients had comparable baseline demographics: 438 in the CRT group and 605 in the surgical group. Patients undergoing CRT had higher proportions of node positivity (64.6% vs 53.1%, P < .001). Locoregional and distant recurrence were less common in the surgical group (23.0% vs 37.2%, P < .001; 6.8% vs 13.3%, P < .001, respectively); however, distant metastatic rates did not differ within the N0 subgroup ( P = .722). On multivariable regression, surgery demonstrated favorable locoregional recurrence (hazard ratio [HR], 0.49; 95% CI, 0.39-0.62; P < .001), distant recurrence (HR, 0.47; 95% CI, 0.31-0.71; P < .001), overall mortality (HR, 0.75; 95% CI, 0.64-0.87; P < .001), and larynx cancer mortality (HR, 0.69; 95% CI, 0.56-0.85; P < .001). Conclusion T4a LSCC survival discrepancies between surgical and nonsurgical treatment are influenced by varying recurrence behaviors. Surgery was associated with superior disease control and improved survival. Beyond the known benefit in locoregional control with surgery, there may be a protective effect on distant recurrence that depends on regional disease burden.


Medicine ◽  
2021 ◽  
Vol 100 (34) ◽  
pp. e27062
Author(s):  
Lucheng Fang ◽  
Wen Wang ◽  
Licai Shi ◽  
Qinjuan Chen ◽  
Xingwang Rao

Cell Cycle ◽  
2021 ◽  
pp. 1-13
Author(s):  
Tianyi Wu ◽  
Guangke Wang ◽  
Xianting Zeng ◽  
Zhanwei Sun ◽  
Shichao Li ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Jingpu Yang ◽  
Zhuping Zhang ◽  
Yin Zhao ◽  
Jinzhang Cheng ◽  
Chang Zhao ◽  
...  

An amendment to this paper has been published and can be accessed via a link at the top of the paper.


2020 ◽  
Vol 24 (12) ◽  
pp. 6781-6795
Author(s):  
Xin Wang ◽  
Boyu Yu ◽  
Qianqian Jin ◽  
Junyi Zhang ◽  
Bingrui Yan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document